vs
Side-by-side financial comparison of PureCycle Technologies, Inc. (PCT) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
PureCycle Technologies, Inc. is the larger business by last-quarter revenue ($2.7M vs $2.2M, roughly 1.2× Instil Bio, Inc.). Instil Bio, Inc. runs the higher net margin — -365.3% vs -697.1%, a 331.8% gap on every dollar of revenue.
PureCycle Technologies, Inc. is a sustainable materials firm with proprietary advanced polypropylene recycling technology. It converts contaminated polypropylene waste into high-purity virgin-equivalent resin for use in consumer goods, automotive parts, packaging and industrial products, serving global partners.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
PCT vs TIL — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $2.7M | $2.2M |
| Net Profit | $-18.8M | $-8.2M |
| Gross Margin | — | — |
| Operating Margin | -2196.1% | -426.3% |
| Net Margin | -697.1% | -365.3% |
| Revenue YoY | — | -19.2% |
| Net Profit YoY | 71.0% | 31.1% |
| EPS (diluted) | $-0.14 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $2.7M | $2.2M | ||
| Q3 25 | $2.4M | $2.2M | ||
| Q2 25 | $1.6M | $2.2M | ||
| Q1 25 | $1.6M | $2.2M | ||
| Q4 24 | $0 | $2.8M | ||
| Q3 24 | $0 | $1.5M | ||
| Q2 24 | $0 | $0 | ||
| Q1 24 | $0 | $0 |
| Q4 25 | $-18.8M | $-8.2M | ||
| Q3 25 | $-28.4M | $-13.6M | ||
| Q2 25 | $-144.2M | $-21.4M | ||
| Q1 25 | $8.8M | $-28.2M | ||
| Q4 24 | $-64.7M | $-11.9M | ||
| Q3 24 | $-90.6M | $-23.0M | ||
| Q2 24 | $-48.2M | $-14.9M | ||
| Q1 24 | $-85.6M | $-24.3M |
| Q4 25 | -2196.1% | -426.3% | ||
| Q3 25 | -1602.2% | -670.0% | ||
| Q2 25 | -2763.5% | -1045.5% | ||
| Q1 25 | -2387.4% | -1363.2% | ||
| Q4 24 | — | -426.1% | ||
| Q3 24 | — | -1582.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -697.1% | -365.3% | ||
| Q3 25 | -1167.5% | -606.0% | ||
| Q2 25 | -8741.8% | -954.2% | ||
| Q1 25 | 559.0% | -1257.8% | ||
| Q4 24 | — | -428.8% | ||
| Q3 24 | — | -1541.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-0.14 | $-1.13 | ||
| Q3 25 | $-0.31 | $-2.01 | ||
| Q2 25 | $-0.81 | $-3.24 | ||
| Q1 25 | $0.05 | $-4.32 | ||
| Q4 24 | $-0.40 | $-1.82 | ||
| Q3 24 | $-0.54 | $-3.54 | ||
| Q2 24 | $-0.29 | $-2.29 | ||
| Q1 24 | $-0.52 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $156.7M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $45.9M | $113.9M |
| Total Assets | $922.7M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $156.7M | $6.6M | ||
| Q3 25 | $234.4M | $5.8M | ||
| Q2 25 | $284.1M | $7.7M | ||
| Q1 25 | $22.5M | $15.4M | ||
| Q4 24 | $15.7M | $8.8M | ||
| Q3 24 | $83.7M | $6.7M | ||
| Q2 24 | $10.9M | $6.8M | ||
| Q1 24 | $25.0M | $5.5M |
| Q4 25 | $45.9M | $113.9M | ||
| Q3 25 | $68.2M | $120.4M | ||
| Q2 25 | $98.9M | $131.7M | ||
| Q1 25 | $238.2M | $144.9M | ||
| Q4 24 | $180.4M | $169.4M | ||
| Q3 24 | $241.4M | $176.3M | ||
| Q2 24 | $291.6M | $195.0M | ||
| Q1 24 | $336.8M | $205.8M |
| Q4 25 | $922.7M | $203.5M | ||
| Q3 25 | $989.1M | $211.8M | ||
| Q2 25 | $1.0B | $231.0M | ||
| Q1 25 | $787.3M | $237.4M | ||
| Q4 24 | $798.4M | $263.6M | ||
| Q3 24 | $788.8M | $272.6M | ||
| Q2 24 | $719.8M | $294.3M | ||
| Q1 24 | $734.0M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-28.7M | $-7.1M |
| Free Cash FlowOCF − Capex | $-42.0M | — |
| FCF MarginFCF / Revenue | -1559.6% | — |
| Capex IntensityCapex / Revenue | 495.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-183.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-28.7M | $-7.1M | ||
| Q3 25 | $-38.5M | $-10.6M | ||
| Q2 25 | $-36.7M | $-14.8M | ||
| Q1 25 | $-38.9M | $-4.2M | ||
| Q4 24 | $-31.8M | $-10.6M | ||
| Q3 24 | $-33.4M | $-20.1M | ||
| Q2 24 | $-40.4M | $-10.6M | ||
| Q1 24 | $-39.2M | $-14.4M |
| Q4 25 | $-42.0M | — | ||
| Q3 25 | $-42.4M | — | ||
| Q2 25 | $-45.3M | — | ||
| Q1 25 | $-53.9M | — | ||
| Q4 24 | $-53.4M | — | ||
| Q3 24 | $-42.6M | — | ||
| Q2 24 | $-50.8M | — | ||
| Q1 24 | $-53.5M | — |
| Q4 25 | -1559.6% | — | ||
| Q3 25 | -1743.1% | — | ||
| Q2 25 | -2747.1% | — | ||
| Q1 25 | -3409.6% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 495.1% | — | ||
| Q3 25 | 160.3% | — | ||
| Q2 25 | 521.5% | — | ||
| Q1 25 | 949.6% | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -4.40× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
